Volume 235, Issue 2

Search all Psychopharmacology articles

February 2018

Special Issue: Psychedelics and related drugs: Therapeutic possibilities and pitfalls?

Issue Editors:

H. Valerie Curran,
Harriet de Wit,
David Nutt

21 articles in this issue

Psychedelics and related drugs: therapeutic possibilities, mechanisms and regulation
H. Valerie Curran
David Nutt
Harriet de Wit
Editorial 14 February 2018 Pages: 373 - 375
(±)-MDMA and its enantiomers: potential therapeutic advantages of R(−)-MDMA
Elizabeth G. Pitts
Daniel W. Curry
Leonard L. Howell
Review 16 December 2017 Pages: 377 - 392
Impact of oral ketamine augmentation on hospital admissions in treatment-resistant depression and PTSD: a retrospective study
John Hartberg
Simone Garrett-Walcott
Angelo De Gioannis
Original Investigation 18 November 2017 Pages: 393 - 398
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
R. L. Carhart-Harris
M. Bolstridge
D. J. Nutt
Original Investigation Open access 08 November 2017 Pages: 399 - 408
A prospective observational study of problematic oral cannabinoid use
Mark A. Ware
Marc O. Martel
Joel Singer
Original Investigation 17 December 2017 Pages: 409 - 417
Do psychoactive drugs have a therapeutic role in compulsivity? Studies on schedule-induced polydipsia
Elena Martín-González
Ángeles Prados-Pardo
Margarita Moreno
Original Investigation 08 January 2018 Pages: 419 - 432
Psychedelics and reconsolidation of traumatic and appetitive maladaptive memories: focus on cannabinoids and ketamine
Liana Fattore
Alessandro Piva
Cristiano Chiamulera
Review 25 November 2017 Pages: 433 - 445
Phytocannabinoids modulate emotional memory processing through interactions with the ventral hippocampus and mesolimbic dopamine system: implications for neuropsychiatric pathology
Roger Hudson
Walter Rushlow
Steven R. Laviolette
Review 24 October 2017 Pages: 447 - 458
Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression
J. B. Stroud
T. P. Freeman
R. L. Carhart-Harris
Original Investigation Open access 30 October 2017 Pages: 459 - 466
Direct comparison of the acute subjective, emotional, autonomic, and endocrine effects of MDMA, methylphenidate, and modafinil in healthy subjects
Patrick C. Dolder
Felix Müller
Matthias E. Liechti
Original Investigation Open access 27 May 2017 Pages: 467 - 479
MDMA-induced indifference to negative sounds is mediated by the 5-HT_2A receptor
K. P. C. Kuypers
R. de la Torre
J. G. Ramaekers
Original Investigation Open access 22 July 2017 Pages: 481 - 490
Psilocybin disrupts sensory and higher order cognitive processing but not pre-attentive cognitive processing—study on P300 and mismatch negativity in healthy volunteers
Anna Bravermanová
Michaela Viktorinová
Tomáš Páleníček
Original Investigation 05 January 2018 Pages: 491 - 503
The hidden therapist: evidence for a central role of music in psychedelic therapy
Mendel Kaelen
Bruna Giribaldi
Robin Carhart-Harris
Original Investigation Open access 02 February 2018 Pages: 505 - 519
Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiences
Theresa M. Carbonaro
Matthew W. Johnson
Roland R. Griffiths
Original Investigation 07 November 2017 Pages: 521 - 534
Long-lasting subjective effects of LSD in normal subjects
Yasmin Schmid
Matthias E. Liechti
Original Investigation Open access 16 September 2017 Pages: 535 - 545
Psychedelics and connectedness
R. L. Carhart-Harris
D. Erritzoe
R. Watts
Commentary 10 August 2017 Pages: 547 - 550
The 21st century psychedelic renaissance: heroic steps forward on the back of an elephant
Ben Sessa
Commentary 23 August 2017 Pages: 551 - 560
Progress and promise for the MDMA drug development program
Allison A. Feduccia
Julie Holland
Michael C. Mithoefer
Review 20 November 2017 Pages: 561 - 571
The abuse potential of kratom according the 8 factors of the controlled substances act: implications for regulation and research
Jack E. Henningfield
Reginald V. Fant
Daniel W. Wang
Review Open access 23 December 2017 Pages: 573 - 589
Regulation of human research with LSD in the United States (1949-1987)
Katherine R. Bonson
Review 17 November 2017 Pages: 591 - 604
Erratum to: MDMA-induced indifference to negative sounds is mediated by the 5-HT_2A receptor
K. P. C. Kuypers
R. de la Torre
J. G. Ramaekers
Erratum 01 August 2017 Pages: 605 - 605

Volume 235, Issue 2

Search

Navigation